- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ORTIVUS Aktie jetzt für 0€ handeln | |||||
| 08:30 | Ortivus AB: Ortivus strengthens liquidity to accelerate the company's growth strategy | 48 | GlobeNewswire (Europe) | Ortivus is enabling increased investment in its growth strategy by further strengthening its financial position with an additional loan of SEK 5 million, following the full utilisation of the SEK 20... ► Artikel lesen | |
| 19.02. | Ortivus AB: Year-end Report January - December 2025 | 174 | GlobeNewswire (Europe) | "We enter 2026 with a strengthened balance sheet, a more efficient organisation, and a portfolio of innovations already making a difference."
October-December 2025Net sales decreased by 12% and amounted... ► Artikel lesen | |
| 13.01. | The observation status for Ortivus AB is removed | 322 | GlobeNewswire | On December 2, 2025, the shares in Ortivus AB (the "Company") were given observation status with reference to a mandatory public offer from Ponderus Invest AB to the other shareholders in Ortivus... ► Artikel lesen | |
| 13.01. | Ortivus AB: Ortivus informs that Ponderus Invest AB has announced the final outcome of the mandatory cash offer to the shareholders of Ortivus Aktiebolag | 125 | GlobeNewswire (Europe) | Ponderus Invest AB ("Ponderus") announced on 2 December 2025 a mandatory cash offer to the shareholders of Ortivus Aktiebolag ("Ortivus" or the "Company") to transfer all of their shares in Ortivus... ► Artikel lesen | |
| 22.12.25 | Ortivus AB: Ortivus informs that Ponderus Invest AB has announced approval from the Swedish Inspectorate of Strategic Products regarding the mandatory cash offer to the shareholders of Ortivus Aktiebolag | 136 | GlobeNewswire (Europe) | Ponderus Invest AB ("Ponderus") announced on 2 December 2025 a mandatory cash offer to the shareholders of Ortivus Aktiebolag ("Ortivus") to transfer all of their shares in Ortivus to Ponderus for SEK... ► Artikel lesen | |
| 18.12.25 | Ortivus AB: The independent bid committee of Ortivus unanimously recommends that shareholders do not accept the mandatory cash offer submitted by Ponderus Invest AB | 245 | GlobeNewswire (Europe) | The independent bid committee of Ortivus AB (publ) ("Ortivus" or the "Company") unanimously recommends that shareholders of Ortivus do not accept the mandatory cash offer submitted by Ponderus Invest... ► Artikel lesen | |
| 17.12.25 | Ortivus AB: Ortivus welcomes Minni Raij as new CFO | 199 | GlobeNewswire (Europe) | Ortivus is pleased to announce the appointment of Minni Raij as the new Chief Financial Officer (CFO) at Ortivus. Minni brings more than two decades of experience in finance and management. Minni will... ► Artikel lesen | |
| 02.12.25 | Ortivus AB receives observation status | 136 | GlobeNewswire | Today, December 2, 2025, Ponderus Invest AB disclosed a mandatory public offer to the other shareholders in Ortivus AB.
The rules of Nasdaq First North Growth Market state that an issuer may... ► Artikel lesen | |
| 02.12.25 | Ortivus AB: Ortivus announces mandatory public offer from Ponderus Invest AB | 129 | GlobeNewswire (Europe) | On 14 November 2025, Ponderus Invest AB announced its intention to return no later than 3 December 2025 with information regarding a potential mandatory public offer to the shareholders of Ortivus AB... ► Artikel lesen | |
| 28.11.25 | Ortivus AB: Interim Report for Ortivus AB (publ) for the period July - September 2025 | 274 | GlobeNewswire (Europe) | "The increased interest we are witnessing in the market and from existing customers, together with the high pace of our product development, gives us a positive outlook for the future."
July-September... ► Artikel lesen | |
| 14.11.25 | Ortivus AB: Ortivus Informs About A Possible Mandatory Bid From Ponderus Invest | 155 | GlobeNewswire (Europe) | Ortivus Aktiebolag ("Ortivus" or the "Company") resolved at an extraordinary general meeting on September 19, 2025 to carry out a fully guaranteed rights issue of B shares corresponding to an issue... ► Artikel lesen | |
| 15.10.25 | Ortivus AB: Ortivus announces that CFO Johan Wewel has decided to leave his position | 152 | GlobeNewswire (Europe) | Ortivus announces today that the company's CFO, Johan Wewel, has decided to leave his position to take up a role outside the Group. Johan Wewel will remain in his current position until 7 January 2026... ► Artikel lesen | |
| 30.09.25 | Ortivus AB: Ortivus publishes information document regarding Rights Issue of shares | 148 | GlobeNewswire (Europe) | THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 19.09.25 | Ortivus AB: Press release from the Extraordinary General Meeting of Ortivus AB regarding Rights Issue | 251 | GlobeNewswire (Europe) | At the Extraordinary General Meeting of Ortivus AB (publ), held in Danderyd on 19 September 2025, the following resolutions were adopted.
For more detailed information, please refer to the full notice... ► Artikel lesen | |
| 09.09.25 | Ortivus AB: Ortivus announces intended allocation of proceeds from the proposed rights issue following agreement with the main shareholder on a new credit facility | 198 | GlobeNewswire (Europe) | Ortivus announced in a press release on 26 August 2025 that the Board of Directors had resolved to propose to an upcoming Extraordinary General Meeting the implementation of a fully guaranteed rights... ► Artikel lesen | |
| 26.05.25 | Ortivus AB: Ortivus receives two-year contract extension from Northern Ireland Ambulance Service (NIAS) | 459 | GlobeNewswire (Europe) | Ortivus AB announces that the Northern Ireland Ambulance Service (NIAS) has formally exercised its contractual right to extend its current agreement with Ortivus by an additional two (2) years. The... ► Artikel lesen | |
| 08.05.25 | Ortivus AB: Interim Report for Ortivus AB (publ) for the period January - March 2025 | 193 | GlobeNewswire (Europe) | "Our ambition is not only to deliver technology, but to be a strategic partner in the transformation of healthcare."
January - March 2025Net sales decreased by 18% and amounted to SEK 18.1 million (22.1).The... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 35,960 | +0,03 % | ANALYSE-FLASH: Jefferies belässt Siemens Healthineers auf 'Buy' - Ziel 60 Euro | NEW YORK (dpa-AFX) - Das Analysehaus Jefferies hat Siemens Healthineers vor den am 7. Mai erwarteten Zahlen zum zweiten Geschäftsquartal mit einem Kursziel von 60 Euro auf "Buy" belassen. Das Update... ► Artikel lesen | |
| FRESENIUS | 44,580 | -0,02 % | Fresenius: Weiteres Wachstum in Sicht - hier besteht erhebliches Potenzial | Der Gesundheitskonzern hat am heutigen Mittwoch seinen Geschäftsbericht für 2025 vorgelegt. Das Management rund um Firmenlenker Michael Sen, dessen Vertrag vor Kurzem verlängert wurde, will den eingeschlagenen... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,930 | +0,10 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,550 | 0,00 % | Brightspring-Aktie erreicht Rekordhoch von 44,88 USD | ||
| TALKSPACE | 5,185 | +0,58 % | Universal Health Services, Inc. to Acquire Talkspace, Inc. | Industry-leading virtual behavioral healthcare platform accelerates outpatient strategy with expanded access to care KING OF PRUSSIA, Pa. and NEW YORK, March 9, 2026 /PRNewswire/ -- Universal... ► Artikel lesen | |
| BETA BIONICS | 9,860 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Introduces Bionic Insights in Bionic Reports - Transforming How Clinicians Understand and Optimize Diabetes Care | ||
| GENEDX | 59,56 | 0,00 % | Craig-Hallum Reaffirms Buy on GeneDx (WGS) With $153 Price Target | ||
| ALIGNMENT HEALTHCARE | 16,860 | 0,00 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| HEARTFLOW | 23,870 | -3,36 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 2,830 | 0,00 % | Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket | ||
| CARL ZEISS MEDITEC | 24,000 | 0,00 % | ANALYSE-FLASH: DZ Bank senkt fairen Wert für Carl Zeiss Meditec - 'Halten' | FRANKFURT (dpa-AFX Broker) - Die DZ Bank hat den fairen Wert für Carl Zeiss Meditec von 42 auf 26 Euro gesenkt, aber die Einstufung auf "Halten" belassen. Nach der zurückgezogenen Jahresprognose im... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 25,560 | 0,00 % | PROCEPT BioRobotics: EAU Guidelines Upgrade Aquablation Therapy to Strong Surgical Recommendation for BPH | Updated European Association of Urology guidelines reflect growing clinical evidence supporting Aquablation therapy in the surgical treatment of benign prostatic hyperplasiaSAN JOSE, Calif., March 23... ► Artikel lesen | |
| GERRESHEIMER | 19,650 | +0,98 % | 2 Milliarden Euro Schulden und Bilanzfehler - was ist bei Gerresheimer los? | Gerresheimer galt lange als stabiles, fast schon unspektakuläres Unternehmen: ein Hersteller von Pharmaverpackungen mit rund 2 Milliarden Euro Umsatz, börsennotiert, solide Aktie. Doch das ist vorbei.... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 20,015 | 0,00 % | Privia Health Group, Inc.: Privia Health Earns 2026 HFMA MAP Award for Revenue Cycle Excellence | ||
| ADAPTHEALTH | 11,280 | 0,00 % | Leerink cuts AdaptHealth stock price target on 2025 earnings decline |
Das Unternehmen ORTIVUS AB kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ORTIVUS AB finden Sie auf Wallstreet Online.